Form CORRESP - Correspondence:
SEC Accession No. 0001213900-19-020749
Filing Date
2019-10-21
Accepted
2019-10-21 17:08:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7866
  Complete submission text file 0001213900-19-020749.txt   8832
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations